08/31/2023 Septerna Bolsters Leadership Team as the Company Advances its Multi-Product Pipeline Toward Clinical Studies Read More
07/11/2023 Septerna Secures $150 Million in Series B Financing to Advance Pipeline of Novel GPCR-targeted Medicines Read More
03/07/2023 Biopharma Dive: GPCR-targeting drugs: A renewed focus on a ubiquitous group of proteins Read More
12/19/2022 Septerna Announces the Formation of a Cross-Functional Scientific and Drug Discovery Advisory Board Read More